Compare SGHT & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | IPI |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.4M | 380.0M |
| IPO Year | 2021 | 2007 |
| Metric | SGHT | IPI |
|---|---|---|
| Price | $3.48 | $41.59 |
| Analyst Decision | Buy | Strong Sell |
| Analyst Count | 7 | 1 |
| Target Price | $9.08 | ★ $25.00 |
| AVG Volume (30 Days) | 273.6K | ★ 460.2K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.16 | ★ 105.14 |
| EPS | N/A | ★ 0.85 |
| Revenue | $77,363,000.00 | ★ $298,328,000.00 |
| Revenue This Year | $11.67 | $5.01 |
| Revenue Next Year | $10.39 | N/A |
| P/E Ratio | ★ N/A | $48.65 |
| Revenue Growth | N/A | ★ 17.13 |
| 52 Week Low | $2.14 | $22.55 |
| 52 Week High | $9.24 | $50.34 |
| Indicator | SGHT | IPI |
|---|---|---|
| Relative Strength Index (RSI) | 34.99 | 50.34 |
| Support Level | $3.29 | $25.80 |
| Resistance Level | $3.76 | $49.06 |
| Average True Range (ATR) | 0.22 | 3.22 |
| MACD | 0.05 | -0.46 |
| Stochastic Oscillator | 7.14 | 38.06 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.